A Systematic Review of Vitamin D Receptor Gene Polymorphisms and Prostate Cancer Risk

Journal of Urology

Volumn 175, Issue 5, 2006, Pages 1613-1623

  Berndt, Sonja I ^a,c   Dodson, Jennifer L ^b   Huang, Wen Yi ^c   Nicodemus, Kristin K ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

calcitriol; genetic; polymorphism; prostate; prostatic neoplasms; receptors; risk factors

Indexed keywords

DNA; POLYADENYLIC ACID; TAQ POLYMERASE; VITAMIN D RECEPTOR;

CANCER RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; HUMAN; INFORMATION RETRIEVAL; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; REVIEW; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

HUMANS; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 33645999062     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00958-4     Document Type: Review

References (60)

1. Schwartz G.G., and Hulka B.S. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10 (1990) 1307
2. Peehl D.M., Skowronski R.J., Leung G.K., Wong S.T., Stamey T.A., and Feldman D. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54 (1994) 805
3. Miller G.J., Stapleton G.E., Hedlund T.E., and Moffat K.A. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res 1 (1995) 997
4. Hanchette C.L., and Schwartz G.G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70 (1992) 2861
5. Hedlund T.E., Moffatt K.A., and Miller G.J. Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31. J Steroid Biochem Mol Biol 58 (1996) 277
6. Miller G.J., Stapleton G.E., Ferrara J.A., Lucia M.S., Pfister S., Hedlund T.E., et al. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Cancer Res 52 (1992) 515
7. Oakley-Girvan I., Feldman D., Eccleshall T.R., Gallagher R.P., Wu A.H., Kolonel L.N., et al. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev 13 (2004) 1325
8. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., et al. Prediction of bone density from vitamin D receptor alleles. Nature 367 (1994) 284
9. Nejentsev S., Godfrey L., Snook H., Rance H., Nutland S., Walker N.M., et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 13 (2004) 1633
10. Arai H., Miyamoto K., Taketani Y., Yamamoto H., Iemori Y., Morita K., et al. A vitamin D receptor gene polymorphism in the translation initiation codon. effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12 (1997) 915
11. Taylor J.A., Hirvonen A., Watson M., Pittman G., Mohler J.L., and Bell D.A. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 56 (1996) 4108
12. Ingles S.A., Ross R.K., Yu M.C., Irvine R.A., La Pera G., Haile R.W., et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89 (1997) 166
13. Blazer III D.G., Umbach D.M., Bostick R.M., and Taylor J.A. Vitamin D receptor polymorphisms and prostate cancer. Mol Carcinog 27 (2000) 18
14. Bodiwala D., Luscombe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., et al. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen 43 (2004) 121
15. Cheteri M.B., Stanford J.L., Friedrichsen D.M., Peters M.A., Iwasaki L., Langlois M.C., et al. Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate 59 (2004) 409
16. Correa-Cerro L., Berthon P., Haussler J., Bochum S., Drelon E., Mangin P., et al. Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet 105 (1999) 281
17. Furuya Y., Akakura K., Masai M., and Ito H. Vitamin D receptor gene polymorphism in Japanese patients with prostate cancer. Endocr J 46 (1999) 467
18. Gsur A., Madersbacher S., Haidinger G., Schatzl G., Marberger M., Vutuc C., et al. Vitamin D receptor gene polymorphism and prostate cancer risk. Prostate 51 (2002) 30
19. Habuchi T., Suzuki T., Sasaki R., Wang L., Sato K., Satoh S., et al. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res 60 (2000) 305
20. Hamasaki T., Inatomi H., Katoh T., Ikuyama T., and Matsumoto T. Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese. Endocr J 48 (2001) 543
21. Huang S.P., Chou Y.H., Wayne Chang W.S., Wu M.T., Chen Y.Y., Yu C.C., et al. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population. Cancer Lett 207 (2004) 69
22. Ingles S.A., Coetzee G.A., Ross R.K., Henderson B.E., Kolonel L.N., Crocitto L., et al. Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res 58 (1998) 1620
23. Kibel A.S., Isaacs S.D., Isaacs W.B., and Bova G.S. Vitamin D receptor polymorphisms and lethal prostate cancer. J Urol 160 (1998) 1405
24. Ma J., Stampfer M.J., Gann P.H., Hough H.L., Giovannucci E., Kelsey K.T., et al. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev 7 (1998) 385
25. Maistro S., Snitcovsky I., Sarkis A.S., da Silva I.A., and Brentani M.M. Vitamin D receptor polymorphisms and prostate cancer risk in Brazilian men. Int J Biol Markers 19 (2004) 245
26. Medeiros R., Morais A., Vasconcelos A., Costa S., Pinto D., Oliveira J., et al. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population. J Hum Genet 47 (2002) 413
27. Suzuki K., Matsui H., Ohtake N., Nakata S., Takei T., Koike H., et al. Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population. Int J Urol 10 (2003) 261
28. Tayeb M.T., Clark C., Haites N.E., Sharp L., Murray G.I., and McLeod H.L. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br J Cancer 88 (2003) 928
29. Tayeb M.T., Clark C., Haites N.E., Sharp L., Murray G.I., and McLeod H.L. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. Saudi Med J 25 (2004) 447
30. Watanabe M., Fukutome K., Murata M., Uemura H., Kubota Y., Kawamura J., et al. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese. Anticancer Res 19 (1999) 4511
31. Chokkalingam A.P., McGlynn K.A., Gao Y.T., Pollak M., Deng J., Sesterhenn I.A., et al. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk. a population-based case-control study in China. Cancer Res 61 (2001) 4333
32. Liu J.H., Li H.W., Wang J.Q., Li M., Xin D.Q., Na X., et al. Vitamin D receptor gene Bsm I polymorphism and the susceptibility to prostate cancer in northern Chinese Han population. Zhonghua Nan Ke Xue 9 (2003) 413
33. Mikhak B., Hunter D., Spiegelman D., and Giovannucci E. Vitamin D receptor (VDR) gene polymorphisms (Bsm1, Fok1, Cdx2) in total prostate cancer (CaP) risk among United States men. AACR Front Cancer Prev Res (2004) p. 141, abstract B120
34. Nam R.K., Zhang W.W., Trachtenberg J., Jewett M.A., Emami M., Vesprini D., et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 1429
35. Yang Y., Wang S., Ye Z., and Yang W. Association of single nucleotide polymorphism of vitamin D receptor gene start codon and the susceptibility to prostate cancer in the Han nationality in Hubei area. Zhonghua Nan Ke Xue 10 (2004) 411
36. Ntais C., Polycarpou A., and Ioannidis J.P. Vitamin D receptor gene polymorphisms and risk of prostate cancer. a meta-analysis. Cancer Epidemiol Biomarkers Prev 12 (2003) 1395
37. Bousema J.T., Bussemakers M.J., van Houwelingen K.P., Debruyne F.M., Verbeek A.L., de La Rosette J.J., et al. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol 37 (2000) 234
38. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177
39. Luscombe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., Fryer A.A., et al. Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes. Carcinogenesis 22 (2001) 1343
40. Xu Y., Shibata A., McNeal J.E., Stamey T.A., Feldman D., and Peehl D.M. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol Biomarkers Prev 12 (2003) 23
41. Figer A., Friedman T., Manguoglu A.E., Flex D., Vazina A., Novikov I., et al. Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. Isr Med Assoc J 5 (2003) 741
42. Williams H., Powell I.J., Land S.J., Sakr W.A., Hughes M.R., Patel N.P., et al. Vitamin D receptor gene polymorphisms and disease free survival after radical prostatectomy. Prostate 61 (2004) 267
43. Hamasaki T., Inatomi H., Katoh T., Ikuyama T., and Matsumoto T. Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese. Urol Int 68 (2002) 226
44. Hamasaki T., Inatomi H., Matsumoto T., and Katoh T. Association of vitamin D receptor gene polymorphism with prostate cancer. Nippon Rinsho, suppl. 11 (2002) 465
45. Ogawa O., Suzuki T., Habuchi T., Sasaki R., Tachiki Y., Akao T., et al. Association of vitamin D receptor gene polymorphism with protection against prostate cancer and benign prostate hyperplasia. Prostate Cancer Prostatic Dis 2 (1999) S24
46. Luscombe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., Fryer A.A., et al. Prostate cancer risk. associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Br J Cancer 85 (2001) 1504
47. Ingles S., Crocitto L., Diep A., Henderson B., Kolonel L., Coetzee G., et al. Vitamin D receptor polymorphisms and prostate cancer in African-Americans. Proc Annu Meet Am Assoc Cancer Res (1997) p. 38, abstract
48. Ekman P., Gronberg H., Matsuyama H., Kivineva M., Bergerheim U.S., and Li C. Links between genetic and environmental factors and prostate cancer risk. Prostate 39 (1999) 262
49. Sarkis A.S., Nagai M.A., Arap S., and Brentani M.M. Molecular characterisation and racial distribution of androgen and vitamin D receptor polymorphisms in patients with prostate cancer, benign prostatic hyperplasia and age-matched healthy controls. Prostate Cancer Prostatic Dis 2 (1999) S30
50. Ingles S.A., La Pera G., Yu M.C., Haile R.W., Ross R.K., and Coetzee G.A. Association of vitamin D receptor polymorphisms with prostate cancer in non-Hispanic white men. Proc Annu Meet Am Assoc Cancer Res (1996) p. 37, abstract
51. Kawaguchi Y., Kanamori M., Ishihara H., Ohmori K., Matsui H., and Kimura T. The association of lumbar disc disease with vitamin-D receptor gene polymorphism. J Bone Joint Surg Am 84-A (2002) 2022
52. Hustmyer F.G., DeLuca H.F., and Peacock M. ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. Hum Mol Genet 2 (1993) 487
53. Price D.K., Franks M.E., and Figg W.D. Genetic variations in the vitamin D receptor, androgen receptor and enzymes that regulate androgen metabolism. J Urol 171 (2004) S45
54. Whitfield G.K., Remus L.S., Jurutka P.W., Zitzer H., Oza A.K., Dang H.T., et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177 (2001) 145
55. Verbeek W., Gombart A.F., Shiohara M., Campbell M., and Koeffler H.P. Vitamin D receptor. no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem Biophys Res Commun 238 (1997) 77
56. Durrin L.K., Haile R.W., Ingles S.A., and Coetzee G.A. Vitamin D receptor 3′-untranslated region polymorphisms. lack of effect on mRNA stability. Biochim Biophys Acta 1453 (1999) 311
57. Mocharla H., Butch A.W., Flick J.T., Weinstein R.S., De Togni P., Jilka R.L., et al. Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC. lack of correspondence with common allelic variants. J Bone Miner Res 12 (1997) 726
58. Colin E.M., Weel A.E., Uitterlinden A.G., Buurman C.J., Birkenhager J.C., Pols H.A., et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 52 (2000) 211
59. Kidd L.C., Paltoo D.N., Wang S., Chen W., Akereyeni F., Isaacs W., et al. Sequence variation within the 5′ regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. Prostate 64 (2005) 272
60. Zhuang S.H., Schwartz G.G., Cameron D., and Burnstein K.L. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Mol Cell Endocrinol 126 (1997) 83